Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise

British Journal of Sports Medicine

Volumn 39, Issue 4, 2005, Pages 232-236

  Rundell, K W ^a   Spiering, B A ^b   Baumann, J M ^a   Evans, T M ^a  

^a MARYWOOD UNIVERSITY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONTELUKAST; PLACEBO;

ADULT; ARTICLE; BICYCLE ERGOMETRY; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; COLD AIR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EXERCISE INDUCED ASTHMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERVENTILATION; MALE; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

ACETATES; ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA, EXERCISE-INDUCED; BRONCHOCONSTRICTION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXERCISE; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYPERVENTILATION; LEUKOTRIENE ANTAGONISTS; MALE; QUINOLINES; TEMPERATURE; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 16444370961     PISSN: 03063674     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjsm.2004.014282     Document Type: Article

References (34)

1. Wilber RL, Rundell L, Szmedra L, et al. Incidence of exercise-induced bronchospasm in Olympic Winter Sport athlefes. Med Sci Sports Exerc 2000;32:732-7.
2. Weiler JM, Ryan EJ 3rd. sthma in United States olympic athletes who participated in the 1998 olympic winter games. J Allergy Clin Immunol 2000;106:207-71.
3. Weiler J, Layton T, Hunt M. Asthma in United States Olympic athletes who participated in the 1990 Summer Games. J Allergy Clin Immunol 1998;102:722-6.
4. Rundell KW, Im J, Mayers LB, et al. Self-reported symptoms and exercise-induced asthma in the elite athlete. Med Sci Sports Exerc 2001;33:208-13.
5. Holzer K, Anderson SD, Douglass J. Exercise in elite summer athletes: challenges for diagnosis. J Allergy Clin Immunol 2002;110:374-80.
6. Anderson SD, Argyros GJ, Magnussen H, et al. Provocation by eucapnic voluntary hyperpnoea to identify exercise-induced bronchoconstriction. Br J Sports Med 2001;35:344-7.
7. Andersan SD, Fitch K, Perry CP, et al. Responses to bronchial challenge submitted for approval to use inhaled beta2 agonists prior to an event at the 2002 Winter Olympics. J Allergy Clin Immunol 2003;111:44-9.
8. Rundell KW, Anderson SD, Spiering BA, et al. Field exercise vs laboratory eucapnic voluntary hyperventilation to identify airway hyperresponsiveness in elite cold weather athletes. Chest 2004;125:909-15.
9. International Olympic Committee Medical Commission. Beta2 adrenoceptor agonists and the Olympic games in Athens, www.olympic.org (accessed January-April 2004).
10. Rundell KW, Wilber RL, Szmedra L, et al. Exercise-induced asthma screening of elite athletes: field vs laboratory exercise challenge. Med Sci Sports Exerc 2000;32:309-10.
11. Argyros GJ, Roach JM, Hurwitz KM, et al. Eucapnic voluntary hyperventilation as a bronchoprovocation technique: development of a standarized dosing schedule in asthmatics. Chest 1990;109:1520-4.
12. Anderson SD, Daviskas E. The mechanism of exercise-induced asthma is ... J Allergy Clin Immunol 2000;106:453-9.
13. Kikawa Y, Hosoi S, Inoue Y, et al. Exercise-induced urinary excretion of leukotriene E4 in children with atopic asthma. Pediatr Res 1991;29:455-9.
14. Reiss TF, Sorkness CA, Stricker W, et al. Effects of montelukast (MK-0476), a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids. Thorax 1997;52:45-8.
15. Jones TR, Labelle M, Belley M, et al. Pharmacology of montelukast sadium (Singulair), a potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol 1995;73:191-201.
16. Leff JA, Busse WW, Pearlman D, et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 1998;339:147-52.
17. Villaran C, O'Neill SJ, Helbling A, et al. Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. J Allergy Clin Immunol 1999;104:547-53.
18. Melo RE, Sole D, Naspitz CK. Exercise-induced bronchoconstriction in children: montelukast attenuates the immediate-phase and late-phase responses. J Allergy Clin Immunol 2003;111:301-7.
19. Peroni DG, Piacentini GL, Ress M, et al. Time efficacy of a single close of montelukast on exercise-induced asthma in children. Pediatr Allergy Immunol 2002;13:434-7.
20. Reiss TF, Hill JB, Harman E, et al. Increased unrinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchoconstriction by montelukast, a cysteinyl leukotriene antagonist. Thorax 1997;52:130-5.
21. Cheng H, Leff JA, Amin R, et al. Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0470) in healthy males and females. Pharm Res 1990;13:445-8.
22. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing - 1999. Am J Respir Crit Care Med 2000;161:309-29.
23. Sterk PJ, Fabbri LM, Quanjer PH, et al. Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J 1993;6:53-83.
24. Folgering H, Palange P, Anderson S. Clinical exercise testing with reference to lung diseases: indications and protocols. Eur Respir Mon 1997;6:51-71.
25. Hurwitz KM, Argyros GJ, Roach JM, et al. Interpretation of eucapnic voluntary hyperventilation in the diagnosis of asthma. Chest 1995;108:1240-5.
26. Helenius IJ, Tikkanen HO, Haahtela T. Occurrence of exercise induced bronchospasm in elite runners: dependence on atopy and exposure to cold air and pollen. Br J Sports Med 1998;32:125-9.
27. Beck KC, Offord KP, Scanlon PD. Bronchoconstriction occurring during exercise in asthmatic subjects. Am J Respir Crit Care Med 1994;149:352-7.
28. Sue-Chu M, Sandsund M, Holand B, et al. Montelukast does not affect exercise performance at subfreezing temperature in highly trained non-asthmatic endurance athletes. Int J Sports Med 2000;21:424-8.
29. Drazen JM. Leukotrienes as mediators of airway obstruction. Am J Respir Crit Care Med 1998;158:5193-200.
30. Manning PJ, Watson RM, Margolskee DJ, et al. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. N Engl J Med 1990;323:1730-9.
31. Finnerty JP, Wood-Baker R, Thomson H, et al. Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene 04 receptor antagonist. Am Rev Respir Dis 1992;145:746-9.
32. Israel E, Dermarkarian R, Rosenberq M, et al. The effects of a 5-lipoxygenase inhibitor on asthma induced by cola, dry air. N Engl J Med 1990;323:1740-4.
33. Dahlen SE, Dahlen B, Eliasson E, et al. Inhibition of allergic bronchoconstriction in asthmatics by the leukotriene-antagonist ICI-204,219. Adv Prostaglandin Thromboxane Leukot Res 1991;21A:461-4.
34. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003;111:913-21; quiz 922.